Estadístiques de Cost-effectiveness analysis of bendamustine plus rituximab as a first-line treatment for patients with follicular lymphoma in Spain.
Visites totals
views | |
---|---|
Cost-effectiveness analysis of bendamustine plus rituximab as a first-line treatment for patients with follicular lymphoma in Spain. | 302 |
Visites totals per mes
views | |
---|---|
October 2024 | 0 |
November 2024 | 1 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
Visites al fitxer
views | |
---|---|
sabater-ahe-cost.pdf(legacy) | 590 |
sabater-ahe-cost.pdf | 35 |
Vistes principals per país
views | |
---|---|
United States | 204 |
France | 22 |
Germany | 21 |
Spain | 13 |
China | 7 |
Ireland | 6 |
United Kingdom | 5 |
Sweden | 4 |
Belgium | 3 |
Poland | 3 |
Italy | 2 |
Russia | 2 |
Slovenia | 2 |
Ukraine | 2 |
Canada | 1 |
Czechia | 1 |
Malaysia | 1 |
New Zealand | 1 |
Visites principals per ciutat
views | |
---|---|
Ashburn | 43 |
Fairfield | 23 |
San Ramon | 17 |
Mountain View | 16 |
Cambridge | 14 |
Ann Arbor | 12 |
Boardman | 11 |
Menlo Park | 11 |
Sunnyvale | 10 |
Dublin | 6 |
Barcelona | 5 |
Seattle | 5 |
Beijing | 3 |
Fremont | 3 |
San Diego | 3 |
Shenzhen | 3 |
Redwood City | 2 |
Rezé | 2 |
San Mateo | 2 |
Cupertino | 1 |
Des Moines | 1 |
Jacksonville | 1 |
Kuala Lumpur | 1 |
Magdeburg | 1 |
Montréal | 1 |
Munich | 1 |
Phoenix | 1 |
Premiá De Mar | 1 |
San Jose | 1 |
Torremolinos | 1 |
Wellington | 1 |
Wilmington | 1 |